NCT05731492View on ClinicalTrials.gov

A Study of Macitentan in Children Below 2 Years of Age

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 14, 2024

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Arterial Hypertension, Pulmonary
Interventions
DRUG

Macitentan

Macitentan will be administered orally.

Trial Locations (4)

37075

Universitatsmedizin Gottingen, Göttingen

79106

Universitatsklinikum Freiburg, Freiburg im Breisgau

04 730

Instytut Pomnik Centrum Zdrowia Dziecka, Warsaw

51 124

Wojewodzki Szpital Specjalistyczny We Wroclawiu, Wroclaw

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY